current
pandem
high
fatal
rate
impos
increasingli
sever
social
econom
impact
worldwid
patient
cardiovascular
diseas
increas
risk
death
often
treat
drug
target
reninangiotensinaldosteron
system
angiotensin
convert
enzym
ace
particularli
import
angiotensin
convert
enzym
inhibitor
acei
angiotensin
ii
receptor
blocker
arb
standard
therapi
high
blood
pressur
heart
failur
hf
current
prescrib
mio
peopl
germani
alon
approx
gener
popul
addit
classic
acei
target
ace
second
isoform
exist
gener
vasoprotect
angiotensin
angiotensin
ii
insensit
acei
identifi
receptor
sar
corona
viru
also
consid
main
receptor
express
particularli
high
lung
epitheli
cell
also
present
cardiac
myocyt
endotheli
cell
level
human
plasma
low
undetect
healthi
human
upregul
patient
heart
failur
acei
upregul
express
reduc
level
angiotensin
ii
downregul
similar
action
shown
arb
action
differ
acei
much
specif
block
receptor
indirectli
increas
angiotensin
ii
level
increas
angiotensin
ii
could
addit
effect
stimul
second
receptor
insensit
arb
receptor
suggest
particip
benefici
effect
arb
may
also
involv
howev
role
axi
fulli
resolv
particularli
net
effect
differ
acei
human
evid
superior
therapeut
efficaci
arb
vs
acei
lack
upregul
acei
arb
led
hypothesi
antihypertens
drug
might
increas
suscept
infect
progress
diseas
whether
patient
treat
acei
arb
advis
switch
therapeut
option
unclear
evid
requir
question
complex
prevail
evid
suggest
benefici
role
high
angiotensin
level
cardiovascular
pulmonari
diseas
argu
pathway
particip
overal
benefit
therapi
acei
also
possibl
cardiovascular
pulmonari
benefit
acei
arb
human
alreadi
infect
outweigh
possibl
neg
impact
increas
spread
answer
one
basic
underli
question
decid
investig
impact
acei
arb
individu
without
hf
circulatori
concentr
surrog
express
cardiac
pulmonari
cell
ii
potenti
relat
concentr
clinic
statu
cardiovascular
pulmonari
outcom
complic
measur
hospit
cardiac
mortal
hypothes
treatment
acei
arb
associ
chang
concentr
plasma
surrog
express
lung
ii
concentr
associ
pulmonari
cardiovascular
outcom
make
use
largescal
data
cohort
studi
biosampl
includ
measur
concentr
plasma
genet
snp
array
data
region
gene
express
data
whole
blood
rnaseq
proteom
data
inflammasom
clinic
outcom
data
deepli
phenotyp
individu
without
acei
arb
medic
continu
monitor
cohort
pandem
next
month
assess
infect
rate
sever
infect
outcom
relat
medic
prior
molecular
clinic
data
concentr
result
first
phase
expect
june
answer
question
whether
acei
therapi
increas
risk
infect
show
whether
acei
arb
differ
effect
level
patient
without
hf
inform
may
help
guid
decis
make
switch
acei
arb
prevent
infect
data
second
surveil
phase
evalu
cours
pandem
get
insight
potenti
causal
relat
drug
intak
infect
defin
action
contain
prevent
infect
studi
support
german
centr
cardiovascular
research
dzhk
